Belgium· BE-AMP-SAM530195-00
Cefuroxim Krka 250 mg
A cefuroxime product containing cefuroxime axetil, registered in Belgium by KRKA d.d. Novo mesto. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Cefuroxime is registered in 15 of 19 countries.
Countries holding a registration under ATC J01DC02 (cefuroxime), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Cefuroxime · ATC J01DC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefuroxime costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.0038 in Finland to $4.41 in Switzerland — a ×1160 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefuroxime · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.41
- IT Italy$1.06
- FI Finland$0.0038
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Cefuroxime Axetil
- Manufacturer
- KRKA d.d. Novo mesto
- Country
- Belgium (BE)
- ATC code
- J01DC02
- ATC class
- Cefuroxime
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb7724073
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
210 interactions on record for cefuroxime.
Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefuroxime · interactions on record
210 records
- 46 moderate
- 164 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefuroxime in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMEDOXINMedochemie Ltd., Limassol
- United StatesCefuroxime axetilAmerican Health Packaging
- FranceCEFUROXIME ARROW 250 mg, comprimé pelliculéARROW GENERIQUES
- FinlandZinnatSandoz A/S
- GermanyCefuraxAristo Pharma Gmbh (Art 57)
- IrelandZinnat 125 mg/5 ml granules for oral suspensionSandoz Pharmaceuticals d.d.
- NorwayCefuroxim 1a pharma1 A Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Cefuroxim 1a Pharma, Cefuroxim Sandoz
- Bulgaria · Cefurocon, Зинат
- Cyprus · Zinnat
- Czechia · Xorimax, Zinnat
- Germany · Cefurax, Cefuroxim 1 A Pharma
- Denmark · Cefudoc
- Estonia · Zinnat
- Spain · Cefuroxima Aurovitas, Cefuroxima Pensa
- France · Cefuroxime Biogaran, Cefuroxime Zentiva
- United Kingdom (Northern Ireland) · Cefuroxime Sandoz, Zinnat
- Greece · Cupax, Medoxem
- Croatia · Xorimax, Zinnat
- Hungary · Zinnat
- Ireland · Cefuroxime Aurobindo, Zinnat
- Iceland · Kefzero
- Italy · Cefuroxima Mylan, Cefuroxima Sandoz
- Lithuania · Cefuroxime Ingen Pharma, Zinnat
- Luxembourg · Cefuroxime Eg, Zinnat
- Malta · Cefuroxime Puren, Zinnat
- Netherlands · Cefuroximaxetil Sandoz B.V.
- Poland · Bioracef, Cefuroxime Axetil Aurovitas
- Portugal · Cefuroxima Aurobindo, Cefuroxima Ccav
- Romania · Cefuroximă Arena, Cefuroxima Atb
- Slovenia · Zinnat
- Slovakia · Zinnat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0016dbe-30ff-489d-bfe8-6be44e390115 GET /v1/drugs/c0016dbe-30ff-489d-bfe8-6be44e390115?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Cefuroxim Krka 250 mg",
"name_fr": "Cefuroxim Krka 250 mg",
"name_nl": "Cefuroxim Krka 250 mg",
"amp_code": "SAM530195-00",
"strengths": [
"300.7150",
"300.7150",
"250.0000",
"250.0000"
],
"pack_count": 2,
"substances": [
"Cefuroxime Axetil",
"Cefuroxime"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Cefuroxime",
"authorisation_numbers": [
"BE530195"
]
}See everything about cefuroxime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.